Synbiotic to Attenuate Resorption of the Skeleton

NARecruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

August 12, 2024

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
OsteoporosisInflammationAging
Interventions
OTHER

SBD111 medical food

SBD111 medical food is a defined microbial assemblage (DMA) consisting of oligofructose and dried berry powder (prebiotics), a Pseudomonas fluorescens, a Lactobacillus brevis, a Leuconostoc mesenteroides, a Lactobacillus plantarum, and a Pichia kudriavzevii (yeast).

OTHER

Placebo

Placebo

Trial Locations (1)

02131

RECRUITING

Hebrew SeniorLife, Roslindale

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Solarea Bio, Inc

INDUSTRY

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Tufts University

OTHER

collaborator

MaineHealth

OTHER

lead

Hebrew SeniorLife

OTHER

NCT06389539 - Synbiotic to Attenuate Resorption of the Skeleton | Biotech Hunter | Biotech Hunter